Sugar water injection may rival steroids for carpal tunnel pain
NCT ID NCT06360510
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study tested whether an injection of 5% dextrose (a sugar solution) works as well as a steroid (betamethasone) to relieve pain and symptoms in people with mild-to-moderate carpal tunnel syndrome. Thirty participants received one of the two ultrasound-guided injections. The goal was to see if the safer, non-steroid option could provide similar relief.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- 5% dextrose injection and betamethasone injection
- What this could lead to
- If dextrose works as well as betamethasone, it could offer a safer, steroid-free option for managing carpal tunnel pain.
- What could go wrong
- This is a small, completed trial with only 30 participants, so results may not apply widely. Dextrose may prove less effective than the standard steroid treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
30 people
The number who actually took part.
- Started
-
May 2023
- Finished
-
May 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
patients that have carpal tunnel syndrome
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Paresthesia and pain symptoms in the region corresponding to the distribution of the median nerve * Detection of mild or moderate CTS by electromyography * One or both of the Phalen test and/or Tinel sign are positive on physical examination * Symptoms have persisted for at least 3 months Exclusion Criteria: * Those diagnosed with polyneuropathy, plexopathy, radiculopathy, thoracic outlet syndrome * Having had surgery or any injection for carpal tunnel syndrome within the last year * History of wrist fracture * Those with rheumatoid arthritis, uncontrolled diabetes, gout, chronic renal failure, malignancy, active systemic infection * Those with cognitive impairment * Coagulopathy or bleeding tendency * Pregnancy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Carpal tunnel syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ankara Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Ankara, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does mixing numbing agent into steroid shots ease hand pain?
- Blood protein may reveal how severe carpal tunnel syndrome is
- A carpal tunnel clue to a silent heart threat?
- Taping technique may offer Drug-Free relief for wrist pain
- One size Doesn't fit all: could pain 'Phenotypes' unlock better carpal tunnel care?
- Ultrasound may reveal hidden clues in carpal tunnel syndrome